![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT to Present at Leerink Partners Global Healthcare Conference 2015
January 22, 2015 16:24 ET
|
Intersect ENT
MENLO PARK, Calif., Jan. 22, 2015 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the Leerink Partners 2015...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT Announces Preliminary 2014 Financial Results
January 12, 2015 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT Announces Enrollment of First Patient in Phase III Study of In-Office Treatment for Recurrent Chronic Sinusitis
December 29, 2014 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Dec. 29, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT to Present at J.P. Morgan Healthcare Conference
December 18, 2014 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT Announces Changes to Board of Directors
December 10, 2014 16:05 ET
|
Intersect ENT
MENLO PARK, Calif., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT to Present at Canaccord Genuity and Piper Jaffray Conferences
November 11, 2014 16:29 ET
|
Intersect ENT
MENLO PARK, Calif., Nov. 11, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT) today announced that management will present an overview of the company's business at the Canaccord Genuity...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT Reports Third Quarter 2014 Results
November 05, 2014 16:01 ET
|
Intersect ENT
MENLO PARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT to Announce Third Quarter Financial Results
October 21, 2014 16:15 ET
|
Intersect ENT
MENLO PARK, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company seeking to improve the quality of life for patients with ear, nose and throat conditions, today...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT Announces Publication of Positive Data From Three Studies of Company's Drug-Eluting Sinus Implants
October 08, 2014 17:06 ET
|
Intersect ENT
MENLO PARK, Calif., Oct. 8, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...
![Intersect ENT Logo](/news-release/logo/305685/0/305685.jpg?lastModified=12%2F09%2F2016%2023%3A36%3A07&size=2)
Intersect ENT Added to Russell 2000 Index
October 01, 2014 16:37 ET
|
Intersect ENT
MENLO PARK, Calif., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Intersect ENT (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today...